- ISIN
- US56400P7069
- CUSIP
- 56400P706
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Jul 28, 2004
Highlights
- Market Cap
- $1.20B
- Enterprise Value
- $1.16B
- EPS (TTM)
- -$0.08
- Total Revenue (TTM)
- $360.78M
- Gross Profit (TTM)
- $285.93M
- EBITDA (TTM)
- $23.43M
- Year Range
- $2.23 - $6.51
- Target Price
- $7.00
- ROA (TTM)
- -3.21%
- ROE (TTM)
- 40.40%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
MNKD Performance Chart
MannKind Corporation (MNKD) is down 31.4% since the beginning of the year. At $4 per share, MNKD is trading 40.2% below its 52-week high of $7. Investors who bought $1,000 worth of MNKD shares 5 years ago would now be looking at an investment worth $861.
Loading charts...
Returns By Period
MannKind Corporation (MNKD) has returned -31.39% so far this year and 3.18% over the past 12 months. Over the last ten years, MNKD has returned -4.63% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
MannKind Corporation
- 1D
- -1.27%
- 1M
- 15.09%
- YTD
- -31.39%
- 6M
- -35.06%
- 1Y
- 3.18%
- 3Y*
- -0.34%
- 5Y*
- -2.96%
- 10Y*
- -4.63%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
MNKD Monthly Returns History
Based on dividend-adjusted daily data since Jul 28, 2004, MNKD's average daily return is +0.07%, while the average monthly return is +1.24%. At this rate, an investment would double in approximately 4.7 years.
Historically, 50% of months were positive and 50% were negative. The best month was May 2017 with a return of +74.0%, while the worst month was Apr 2008 at -56.5%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 5 months.
On a daily basis, MNKD closed higher 46% of trading days. The best single day was Sep 4, 2018 with a return of +89.1%, while the worst single day was Apr 9, 2008 at -59.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.94% | -43.25% | -25.30% | 15.51% | 33.22% | 3.18% | -31.39% | ||||||
| 2025 | -9.95% | -7.77% | -5.81% | 0.20% | -17.66% | -9.88% | 1.07% | 21.43% | 16.99% | 4.10% | -4.29% | 5.98% | -11.82% |
| 2024 | -8.24% | 23.05% | 10.22% | -9.27% | 13.63% | 11.78% | 10.34% | 8.68% | 0.48% | 12.40% | -4.10% | -5.16% | 76.65% |
| 2023 | 3.80% | -3.47% | -22.35% | -6.10% | 20.52% | -12.28% | 12.29% | 0.88% | -10.41% | 3.87% | -15.62% | 0.55% | -30.93% |
| 2022 | -14.65% | -29.76% | 40.46% | -14.95% | 33.55% | -8.85% | -9.45% | 5.80% | -15.34% | 9.39% | 38.46% | 12.61% | 20.59% |
| 2021 | 12.46% | 62.22% | -31.35% | 16.58% | -3.28% | 23.30% | -24.77% | 17.07% | -9.37% | 8.28% | -1.70% | -5.62% | 39.62% |
Benchmark Metrics
MannKind Corporation has an annualized alpha of 6.38%, beta of 1.11, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since July 28, 2004.
- This stock participated in 191.29% of S&P 500 Index downside but only 114.78% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 6.38%
- Beta
- 1.11
- R²
- 0.07
- Upside Capture
- 114.78%
- Downside Capture
- 191.29%
Return for Risk
Risk / Return Rank
MNKD ranks 45 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for MannKind Corporation (MNKD) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MNKD | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.99 | ||
| Sortino ratioReturn per unit of downside risk | -2.15 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.37 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | 0.05 | 2.78 | -2.73 |
| Martin ratioReturn relative to average drawdown | 0.11 | 12.44 | -12.33 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the MannKind Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the MannKind Corporation was 99.41%, occurring on May 3, 2017. The portfolio has not yet recovered.
The current MannKind Corporation drawdown is 96.72%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2017 bear market2017 | -99.41%May 2017 | 12y 7mo | — | 21y 9moSep 2004 - now |
2004 bear market2004 | -29.12%Aug 2004 | 16d | 26d | 1mo 12dJul 2004 - Sep 2004 |
2004 pullback2004 | -1.22%Sep 2004 | 0s | 2d | 2dSep 2004 - Sep 2004 |
Drawdown Indicators
| MNKD | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.41% | -56.78% | -42.63% |
Max Drawdown (1Y)Largest decline over 1 year | -63.29% | -9.10% | -54.19% |
Max Drawdown (3Y)Largest decline over 3 years | -69.35% | -18.90% | -50.45% |
Max Drawdown (5Y)Largest decline over 5 years | -69.35% | -25.43% | -43.92% |
Max Drawdown (10Y)Largest decline over 10 years | -88.72% | -33.92% | -54.80% |
Current DrawdownCurrent decline from peak | -96.72% | -1.80% | -94.92% |
Average DrawdownAverage peak-to-trough decline | -81.12% | -10.71% | -70.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.13% | 2.03% | +28.10% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of MannKind Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how MannKind Corporation is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for MNKD relative to other companies in the Biotechnology industry. Currently, MNKD has a P/S ratio of 3.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with MNKD
Add MannKind Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with MNKD